By Geert De Lombaerde From Nashville Post New treatment will be company’s biggest seller Cumberland Pharmaceuticals has signed a definitive agreement to buy an antibiotic treatment for some skin infections and hospital-acquired pneumonia from a much larger publicly traded company. Cumberland’s deal to take over Vibativ from Theravance Biopharma calls for the local firm to […]